Skip to content

Justyna Ciejka

Justyna Ciejka, Ph.D.
Researcher
Laboratory of Virology MCB
E-mail: Justyna.Ciejka [AT] uj.edu.pl

Research interests

  • Development of novel inhibitory compounds against viral diseases.

Grants And Awards
Show More

    • 2017 – 2020: Hybrid adsorbents for concentrating, purification and detection viruses. Sonata funding scheme (PI: Justyna Ciejka).
    • 2013 – 2015: Functionalized nanoparticles for prophylaxis and treatment of coronaviral infections. Ventures research grant and stipend from the Foundation of Polish Science. Ventures funding scheme (PI: Justyna Ciejka).
    • 2011 –2013: Stipend within the TEAM project „Polymeric Functional Materials for Biomedical Applications” (POLYMED) from the Foundation of Polish Science.
    • 2008 –2010: Stipend for the best students APedukacja
    • 2008 – 2009: Stipend for the best students Faculty of Chemistry, Jagiellonian University.

    • 2015: PhD degree, Faculty of Chemistry, Krakow, Poland
    • 2010 - 2015: PhD student at Faculty of Chemistry JU.
    • 2005-2010: Master degree thesis, Faculty of Chemistry, Krakow, Poland
    • 2008-2010: Professional College: Cosmetology

    1. Pachota M, Klysik K, Synowiec A, Ciejka J, Szczubialka K, Pyrc K, Nowakowska M. (2017) Inhibition of herpes simplex viruses by cationic dextran derivatives. Journal of Medicinal Chemistry. 60(20):8620-8630.
    2. Ciejka J., Wolski K., Nowakowska M., Pyrc K., Szczubialka K., Biopolymeric nano/microspheres for selective and reversible adsorption of coronaviruses, Materials Science and Engineering C, 2017, 76: 735-742. IF – 3,420.
    3. Milewska A., Kaminski K., Ciejka J., Kosowicz K., Zeglen S., Wojarski J., Nowakowska M., Szczubialka K., Pyrc K., HTCC: broad range inhibitor of coronavirus entry, Plos One, 2016, 11. IF – 3,535.
    4. Ciejka J., Milewska A., Wytrwal M., Wojarski J., Golda A., Ochman M., Nowakowska M., Szczubialka K., Pyrc K., Novel polyanions inhibiting replication of influenza viruses, Antimicrobial Agents and Chemotherapy, 2016, 60: 1955-1966. IF – 4,547.
    5. Lorkowska-Zawicka B., Kaminski K., Ciejka J., Szczubiałka K., Białas M., Okoń K., Adamek D., Nowakowska M., Jawień J., Olszanecki R., Korbut R., Inactivation of heparin by cationically modified chitosan, Marine Drugs, 2014, 12: 3953-3969. IF – 4,031.
    6. Milewska A., Ciejka J., Kaminski K., Karewicz A., Bielska D., Zeglen S., Karolak W., Nowakowska M., Potempa J., Bosch B.J., Pyrc K., Szczubialka K., Novel polymeric inibitors of HCoV-NL63, Antiviral Research, 2013, 97: 112-121. IF – 4,909.
    7. Kamiński K., Płonka M., Ciejka J., Szczubiałka K., Nowakowska M., Lorkowska B., Korbut R., Lach R., Cationic derivatives of dextran and hydroxypropylcellulose as novel potential heparin antagonists, Journal of Medicinal Chemistry, 2011, 54 (19): 6586-6596. IF – 5,589

    1. P. 416 749: The use of cationically modified dextran for the treatment of infections caused by HSV-1 virus.
    2. P. 413 055: The use of polymers in the treatment and prevention of infections caused by human rhinoviruses.
    3. P. 409 016: The use of polymers in the treatment and prevention of infections caused by influenza virus.
    4. P. 409 015: The use of polymers in the treatment and prevention of infections caused by human metapneumovirus virus.